Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd D Armstrong

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
JCI Insight|October 19, 2018
Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancerHeather L Kinkead, Alexander Hopkins, Eric Lutz, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
Mimicking the breast metastatic microenvironment: characterization of a novel syngeneic model of HER2<sup>+</sup> breast cancerAaron G Baugh, Edgar Gonzalez, Valerie H Narumi, et al.
Genome Biology|May 14, 2021
Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathwaysWon Jin Ho, Rossin Erbe, Ludmila Danilova, et al.
Science Advances|April 2, 2020
Nanoparticle interactions with immune cells dominate tumor retention and induce T cell-mediated tumor suppression in models of breast cancerPreethi Korangath, James D Barnett, Anirudh Sharma, et al.
JCI Insight|December 8, 2023
CD4 T cell-activating neoantigens enhance personalized cancer vaccine efficacyAmanda L Huff, Gabriella Longway, Jacob T Mitchell, et al.
Cancer Research|February 8, 2024
Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer ProgressionDaniel J Zabransky, Yash Chhabra, Mitchell E Fane, et al.
International Journal of Cancer|May 17, 2014
Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survivalAlessandra De Remigis, Tanja D de Gruijl, Jennifer N Uram, et al.
Cancer Discovery|June 15, 2019
Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated FibroblastsEla Elyada, Mohan Bolisetty, Pasquale Laise, et al.
The Journal of Clinical Investigation|July 20, 2021
Systemic inhibition of PTPN22 augments anticancer immunityWon Jin Ho, Sarah Croessmann, Jianping Lin, et al.
Oncoimmunology|November 15, 2021
Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resectionDaniel Delitto, Daniel J Zabransky, Fangluo Chen, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
JCI Insight|October 19, 2018
Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancerHeather L Kinkead, Alexander Hopkins, Eric Lutz, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
Mimicking the breast metastatic microenvironment: characterization of a novel syngeneic model of HER2<sup>+</sup> breast cancerAaron G Baugh, Edgar Gonzalez, Valerie H Narumi, et al.
Genome Biology|May 14, 2021
Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathwaysWon Jin Ho, Rossin Erbe, Ludmila Danilova, et al.
Science Advances|April 2, 2020
Nanoparticle interactions with immune cells dominate tumor retention and induce T cell-mediated tumor suppression in models of breast cancerPreethi Korangath, James D Barnett, Anirudh Sharma, et al.
JCI Insight|December 8, 2023
CD4 T cell-activating neoantigens enhance personalized cancer vaccine efficacyAmanda L Huff, Gabriella Longway, Jacob T Mitchell, et al.
Cancer Research|February 8, 2024
Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer ProgressionDaniel J Zabransky, Yash Chhabra, Mitchell E Fane, et al.
International Journal of Cancer|May 17, 2014
Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survivalAlessandra De Remigis, Tanja D de Gruijl, Jennifer N Uram, et al.
Cancer Discovery|June 15, 2019
Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated FibroblastsEla Elyada, Mohan Bolisetty, Pasquale Laise, et al.
The Journal of Clinical Investigation|July 20, 2021
Systemic inhibition of PTPN22 augments anticancer immunityWon Jin Ho, Sarah Croessmann, Jianping Lin, et al.
Oncoimmunology|November 15, 2021
Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resectionDaniel Delitto, Daniel J Zabransky, Fangluo Chen, et al.
Pageof 5